Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.49 CAD | 0.00% | -5.77% | +66.10% |
Apr. 25 | NurExone Biologic Announces OTCQB Listing And DTC Eligibility | MT |
Apr. 02 | NurExone Biologic Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+66.10% | 23.64M | |
+44.48% | 55.07B | |
-0.86% | 41.79B | |
+44.25% | 40.22B | |
-7.59% | 28.17B | |
+12.30% | 26.28B | |
-21.83% | 18.93B | |
+7.15% | 13.03B | |
+29.40% | 12.26B | |
+25.15% | 12.21B |
- Stock Market
- Equities
- NRX Stock
- News NurExone Biologic Inc.
- NurExone Launches Licensing Efforts For ExoTherapy Platform